Home » Topics » Disease categories and therapies » Respiratory

Respiratory
RSS

NK1/NK2 antagonist research at Hoechst Marion Roussel

Nov. 1, 1996

New antiallergic agents from Takeda

Nov. 1, 1996

Dual H1/NK1 antagonists as potential antiallergics

Nov. 1, 1996

GV-1101 available for licensing

Oct. 25, 1996

Gelsolin enters clinical trials

Oct. 25, 1996

Ohmeda and AGA expand agreement on NO

Oct. 25, 1996

Rhone-Poulenc Rorer submits sNDA for new Tilade formulation

Oct. 25, 1996

Chiroscience selects clinical candidate for asthma

Oct. 25, 1996

Potent, non-redox 5-LO inhibitor identified by Merck Frosst

Oct. 25, 1996

Lilly discloses 5-LO inhibitors

Oct. 25, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 12, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 12, 2025.
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...
CTAD 2025: The challenges of combination therapies for dementia
BioWorld Science
At the Clinical Trials on Alzheimer’s Disease 2025 meeting, a panel of experts discussed the need for developing combination therapies for the complex diseases...
DEE-lightful: Praxis’ phase II results allow stock to flex its muscle
BioWorld
Positive efficacy results led to Praxis Precision Medicines Inc.’s phase II Embold study in developmental and epileptic encephalopathies (DEEs) being halted...